XOMA, Ltd. (NASDAQ: XOMA) is focused on the discovery and development of antibodies, one of the most powerful and transformative fields of drug innovation today. By building on its pioneering proprietary pipeline, antibody discovery and development platform, and multiple revenue streams, the company is creating novel human antibody therapeutics that could revolutionize medicine and reshape people’s lives. For further information, visit the Company’s web site at www.xoma.com.
- 18 years ago
QualityStocks
XOMA, Ltd. (NASDAQ: XOMA)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Belden Inc. (NYSE: BDC) To Acquire RUCKUS Networks for $1.85 Billion
Belden (NYSE: BDC) announced it has entered into a definitive agreement to acquire RUCKUS Networks from Vistance Networks for approximately $1.85…
-
From Capital to Catalysts: Canamera Energy Metals Corp.’s (CSE: EMET) (OTCQB: EMETF) $10M Raise Sets the Stage for Rare Earth Exploration Momentum
Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF)and may include paid…
-
Forward Industries Inc. (NASDAQ: FWDI) Adds Digital Asset and Traditional Finance Executive Mark Brazier as Chief Financial Officer
Forward Industries has appointed experienced financial executive Mark Brazier to serve as Chief Financial Officer.…